Abstract
This prospective, observational study was carried out in a cohort of 3109 consecutive patients who underwent PCI in 79 centres located throughout France. Treatment was entirely at the discretion of the clinician, and patients were followed up for one month. The following data were collected at inclusion in the registry: patient demographics, medical history, prescribed treatment, cardiovascular risk factors (hyperlipidaemia, hypertension, diabetes, smoking), and the clinical context of the PCI. Procedural data recorded included; treated arteries, reperfusion (thrombolysis in myocardial infarction (TIMI) flow grade), residual stenosis, number of stents, length of stents, and, if measured, creatine phosphokinase concentration. During one month follow up the following clinical events were recorded: death (vascular or non-vascular), Q wave or non-Q wave MI (myocardial infarction), repeated revascularisation of the target vessel, ischaemic or haemorrhagic stroke, peripheral or major haemorrhagic complications, and any other clinical event requiring specific treatment. All participating centres were visited several times to check source data. All data were double entered onto a database and checked for integrity and consistency.